Epstein–Barr virus in autoimmune diseases

É Toussirot, J Roudier - Best practice & research Clinical rheumatology, 2008 - Elsevier
Autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA),
and primary Sjögren's syndrome (pSS) are complex disorders with a genetic background …

The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases

É Toussirot - Inflammation & Allergy-Drug Targets (Formerly …, 2012 - ingentaconnect.com
IL-23 is a pro-inflammatory cytokine belonging to the IL-12 cytokine family. IL-23 is essential
for the differentiation of Th17 lymphocytes, a subtype of T lymphocyte implicated in chronic …

Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive …

É Toussirot, F Aubin - RMD open, 2016 - rmdopen.bmj.com
Paradoxical adverse events (PAEs) have been reported during biological treatment for chronic
immune-mediated diseases. PAEs are defined as the occurrence during biological agent …

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide series

É Toussirot, É Houvenagel, V Goëb, D Fouache… - Joint Bone Spine, 2012 - Elsevier
OBJECTIVES: To describe cases of new onset of inflammatory bowel disease (IBD) in patients
with inflammatory rheumatic disease (IRD) receiving anti-TNF-α therapy. METHODS: A …

Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases

…, M Samimi, S Pavy, E Pertuiset, E Toussirot… - …, 2009 - academic.oup.com
Objective. TNF blockers have been recently evaluated for treating refractory sarcoidosis and
could be efficient. However, several cases of sarcoidosis have been diagnosed during anti-…

Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre …

…, M Hamidou, S Park, X Puéchal, E Toussirot… - …, 2016 - academic.oup.com
Objective. We describe myelodysplastic syndrome (MDS)–associated systemic inflammatory
and autoimmune diseases (SIADs), their treatments and outcomes and the impact of SIADs …

The contribution of adipose tissue and adipokines to inflammation in joint diseases

E Toussirot, G Streit, D Wendling - Current medicinal chemistry, 2007 - ingentaconnect.com
Adipokines are proteins produced by white adipose tissue, which is an active secretory organ.
Regulation of immune and inflammatory responses is among the multiple physiological …

Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases

…, S De Vita, M Zeher, JA Bosch, E Toussirot… - Medicine, 2005 - journals.lww.com
To define the clinical and immunologic pattern of expression of Sjögren syndrome (SS)
associated with chronic hepatitis C virus (HCV) infection, we conducted a multicenter study …

Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis

É Toussirot, G Streit, NU Nguyen, G Dumoulin… - Metabolism, 2007 - Elsevier
Adipokines such as leptin and adiponectin are involved in the regulation of inflammation.
Ghrelin, a gastric peptide playing a role in the appetite regulation, possesses anti-inflammatory …

Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: a randomized clinical trial

…, C Richez, ME Truchetet, D Wendling, E Toussirot… - Jama, 2022 - jamanetwork.com
Importance Few treatments are available for patients with glucocorticoid-dependent
polymyalgia rheumatica. IL-6 antagonists may reduce disease activity in patients with active …